AI assistant
Sending…
SHERWIN WILLIAMS CO — Director's Dealing 2021
Aug 3, 2021
29898_dirs_2021-08-03_f92235bb-6809-40bb-a1df-d0da0ef88223.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SHERWIN WILLIAMS CO (SHW)
CIK: 0000089800
Period of Report: 2021-07-30
Reporting Person: Padden Brian E (President, Consumer Brands Grp)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-30 | Common Stock | M | 699 | $75.91 | Acquired | 8313 | Direct |
| 2021-07-30 | Common Stock | S | 3153 | $289.53 | Disposed | 5160 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-30 | Employee Stock Option (Right to Buy) | $75.91 | M | 558 | Disposed | 2024-10-21 | Common Stock (558) | Direct |
| 2021-07-30 | Employee Stock Option (Right to Buy) | $75.91 | M | 141 | Disposed | 2024-10-21 | Common Stock (141) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 11242.35 | Indirect |
Footnotes
F1: All amounts reported in this Form 4 have been adjusted to reflect The Sherwin-Williams Company's 3-for-1 stock split, effective March 31, 2021.
F2: Represents the number of shares of common stock attributable to the reporting person's participation in The Sherwin-Williams Company 401(k) Plan (formerly known as The Sherwin-Williams Company Employee Stock Purchase and Savings Plan) per the trustee's 6/30/2021 statement.
More from SHERWIN WILLIAMS CO
Regulatory Filings
2026
May 20
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 11
Proxy Solicitation & Information Statement
2026
Mar 11
Proxy Solicitation & Information Statement
2026
Mar 11
Regulatory Filings
2026
Feb 27